Search
for
Sort by
Research 31–60 of 1000+
- The population dynamics of cancer: a Darwinian perspective
- Chapter 23. Therapeutic Control of Androgen Action
- Hormone Blocking Anticancer Drugs
- This Month in Adult Urology
- Pharmacological basis for clinical use of antiandrogens
- PHARMACOLOGICAL BASIS FOR CLINICAL USE OF ANTIANDROGENS
- Metformin and Malignant Tumors: Not Over the Hill
- Forum
- Roles of p38- and c-jun NH2-terminal kinase-mediated pathways in 2-methoxyestradiol-induced p53 induction and apoptosis
- Prostate-specific antigen as a diagnostic marker in female hyperandrogenism
- Steroidal 5α-reductase and 17α-hydroxylase/17,20-lyase (CYP17) inhibitors useful in the treatment of prostatic diseases
- Characteristics of flutamide action on prostatic and testicular functions in the rat
- Prostate cancer update: 2007
- Prostate cancer update: 2007
- Association between male pattern baldness and prostate disease: A meta-analysis
- The Transcriptional Co-Activator cAMP Response Element-Binding Protein-Binding Protein Is Expressed in Prostate Cancer and Enhances Androgen- and Anti-Androgen-Induced Androgen Receptor Function
- The dihydrotestosterone (DHT) hypothesis of prostate cancer and its therapeutic implications
- Finasteride does not prevent bladder cancer: A secondary analysis of the Medical Therapy for Prostatic Symptoms Study
- Oral administration of berberine represses macrophage activation-associated benign prostatic hyperplasia: a pivotal involvement of the NF-κB
- Relative binding affinity of novel steroids to androgen receptors in hamster prostate
- The role of dutasteride in the treatment of benign prostatic obstruction and related conditions
- Species Differences in Prostatic Steroid 5<i>α</i>-Reductases of Rat, Dog, and Human
- Cinnamomi Cortex (Cinnamomum verum) Suppresses Testosterone-induced Benign Prostatic Hyperplasia by Regulating 5α-reductase
- Efficacy and Side Effects of Drugs Commonly Used for the Treatment of Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia
- Male Pattern Baldness in Relation to Prostate Cancer–Specific Mortality: A Prospective Analysis in the NHANES I Epidemiologic Follow-up Study
- Is prostate-specific antigen a potential new marker of androgen excess in polycystic ovary syndrome?
- Rat steroid 5α-reductase kinetic characteristics: Extreme pH-dependency of the type II isozyme in prostate and epididymis homogenates
- Abiraterone and spironolactone in prostate cancer: a combination to avoid
- Increased DHT levels in androgenic alopecia have been selected for to protect men from prostate cancer
- THERAPEUTIC HOTLINE: Treatment of androgenic alopecia with finasteride may result in a high grade prostate cancer in patients: fact or fiction?